Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,106 public trials 2,040 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Effect of IAM With an I-gel® on Ventilation Parameters in Simulated Pediatric OHCA

NCT05498402

Conditions: Cardiac Arrest, Cardiopulmonary Arrest, Cardiovascular Diseases, +16 more
Locations: ACE Genève Ambulances Chêne-Bougeries, Canton of Geneva, Switzerland

Ambulances de la Ville de Sion Sion, Valais, Switzerland

Genève TEAM Ambulances Geneva, Switzerland

SK Ambulances Geneva, Switzerland

View Trial Details

Completed

Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

NCT04774744

Conditions: Acute Myeloid Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

NCT01336920

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +22 more
Locations: Emory University, Winship Cancer Institute Atlanta, Georgia, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma

NCT00574730

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Unversity of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

NCT01696461

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +31 more
Locations: H. Lee Moffitt Cancer Center Tampa, Florida, United States

Emory University Atlanta, Georgia, United States

University of Chicago Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

NCT05303376

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +23 more
Locations: JOHESE UNITAS Hospital Lyttelton, Centurion, South Africa

JOHESE ZAH Hospital Pretoria, Gauteng, South Africa

Central City Clinical Hospital of Ivano-Frankivsk City Council Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine

City Clinical Hospital #1 of Ivano-Frankivsk City Council Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine

View Trial Details

Completed

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

NCT06035614

Conditions: Autoimmune Diseases, Dermatologic Disease, Hematologic Diseases, +16 more
Locations: King Abdullah University Hospital Ar Ramtha, Jordan

View Trial Details

Completed

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

NCT00049673

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

Cross Cancer Institute Edmonton, Alberta, Canada

BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

View all 18 locations

View Trial Details

Completed

A Food Effect Study of LP-168 Tablets in Healthy Subjects

NCT05917964

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

NCT01951885

Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +41 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions